Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy - Wikidata - wikimedia - TriplyDB

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

http://www.wikidata.org/entity/Q57267014

about

Recombinant allergens: the present and the future Antigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Immunological mechanisms of allergen-specific immunotherapy A novel adjuvant-allergen complex, CBP-rFel d 1, induces up-regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro.Nanoparticle-allergen complexes for allergen immunotherapy.Designing a multimer allergen for diagnosis and immunotherapy of dog allergic patients.Immunological mechanisms of specific immunotherapy with pollen vaccines: implications for diagnostics and the development of improved vaccination strategies.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Recent advances in the use of nanoparticles for allergen-specific immunotherapy.Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy.An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen.

P2860

Q26996701-D9E21C43-E16D-4A5D-B313-62B7238B1A0E Q27687250-76EA7F84-AAEF-467B-9F91-D8A087A38369 Q28265326-E7232533-499D-4A07-9B59-852A40579DC6 Q30768718-AF90A318-C736-45A5-BF3F-F2EACEF8A9BF Q33834985-F7EB5EBD-7035-472C-84D0-418BEF6D1DB6 Q34420851-013FA000-A3AB-4822-BCD9-4A17779F34BF Q35193549-A88A688B-2774-4DDB-B818-4EA24D402D22 Q36056484-EACAF34E-CA36-487A-BAEA-40F4BD688220 Q38802840-148310EB-E9D3-4DF9-B32A-14BB0A653696 Q39321330-4BBD0D05-3A8D-4F26-A4B1-D6920892E756 Q52592904-DDBF226B-EA93-4CB9-9D15-4B9239DB019F

P2860

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

http://www.wikidata.org/entity/Q57267014

description

scientific article published on 01 December 2002

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в грудні 2002

@uk

name

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@en

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@nl

type

label

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@en

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@nl

prefLabel

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@en

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@nl

P1433

Q57267014-0B24563F-CB3F-4260-877D-942CC3E710EA

P1476

Q57267014-DFD902D9-E4ED-4599-B71E-5C59D16F295F

P2093

Q57267014-6F8E10F2-9BFF-48B0-942F-DD2A084CF0C0

Q57267014-889ED0EF-62D2-4554-A842-369FF7EA0654

Q57267014-DCC8F0AF-9E08-4991-AADA-A171A040AFFF

P2860

Q57267014-00E002DC-56F3-4990-B00F-ED3D1FF5EFC4

Q57267014-00FA94C7-CDE7-46C2-A9FA-0F13D0F93B1D

Q57267014-145D5199-EEED-442F-BCAA-E34E31A2DEF2

Q57267014-493E9D95-549D-47B9-A46A-B19826483CF1

Q57267014-5C99E403-3874-4BF4-96CC-08AE5C3377CC

Q57267014-5D5BCBBE-C848-4E31-AE97-F3AC779B32F9

Q57267014-6B7D5BD7-548A-485C-926F-D82E1463A1C7

Q57267014-8A0D86E2-0249-4B94-A01F-323D8E22901B

Q57267014-9246777B-B5B6-4CAB-97AA-E2225E3914D3

Q57267014-A8BE6BF9-400E-45C1-AFC6-DB64D5353753

P304

Q57267014-D0D827E2-1287-43DA-AC3B-F2A6240F7BB9

P31

Q57267014-BB72885F-C5EB-4612-83DB-3144754C59C1

P356

Q57267014-912E7FFE-F77C-42F9-8ED8-6A4A2E70E9B5

P407

Q57267014-B3E29424-D911-4E6E-BA62-10D951B0626A

P433

Q57267014-A59F3112-2B98-435B-9CC2-C2DC9D00E447

P478

Q57267014-0443429B-CA73-43B5-AC31-447B050FE2A8

P50

Q57267014-2F6BA711-0182-4234-8B33-C4E2FDC5299E

Q57267014-537B4C16-E0C4-4B0C-AB1B-30F02126EF88

Q57267014-D5FA7C51-D4F6-4760-A0FA-EDE82F379683

Q57267014-DF173D2F-BD56-4D7C-AACF-570E1FD0CB6C

P577

Q57267014-48784166-B626-4B3E-A7EA-9EBB19022B29

P698

Q57267014-32F37848-A332-47E0-BC28-A24622CA3B26

P921

Q57267014-D0CF6941-B8FD-4F2D-B5D1-B00C2C39BF41

P932

Q57267014-066663AD-653A-4AB6-A8CB-9F64BEB44011

P356

J.1365-2567.2002.01535.X

P1433

P1476

Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy

@en

P2093

Dietrich Kraft

http://www.w3.org/2001/XMLSchema#string

Gerhard Dekan

http://www.w3.org/2001/XMLSchema#string

Rudolf Valenta

http://www.w3.org/2001/XMLSchema#string

P2860

Sensitisation, asthma, and a modified Th2 response in children exposed to cat allergen: a population-based cross-sectional study.

Immunostimulatory DNA and applications to allergic disease.

Long-term clinical efficacy of grass-pollen immunotherapy.

The other side of the coin: the protective role of the TH2 cytokines.

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper.

Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

Major allergen Phl p Vb in timothy grass is a novel pollen RNase.

A placebo-controlled trial of immunotherapy with two extracts of Dermatophagoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG, and IgG subclasses.

A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections.

P304

523-529

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2567.2002.01535.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P50

Marianne van Hage

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12460198

http://www.w3.org/2001/XMLSchema#string

P921

P932

1782826

http://www.w3.org/2001/XMLSchema#string